The 12th edition expands on non-pharmacological management, focusing on how a patient's daily life and mental health intersect with digestive health:
"Finally, a textbook that keeps up with the explosion of new drugs in IBD. The tables comparing efficacy of ustekinumab vs. risankizumab are worth their weight in gold." — s gastrointestinal and liver disease 12th edition hot
The text has been expanded to include the latest biological agents and novel small molecules that have revolutionized the treatment of Inflammatory Bowel Disease (IBD) , including subcutaneous formulations like infliximab. The latest edition introduces critical new content and
The latest edition introduces critical new content and a fresh senior editorial team led by Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox New Chapters : Covers contemporary clinical challenges including the Rubin, and C
Over 1,100 full-color illustrations and practice-focused algorithms designed for rapid reference in clinical settings.
Below is a short, creative, and informative “lifestyle and entertainment” feature piece written as if it were a magazine section inspired by that authoritative text. It translates key GI/liver health concepts into everyday habits, diet, social drinking, travel, and even “gut-friendly” leisure.